The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines

Cancer Management and Research

Volumn 4, Issue 1, 2012, Pages 195-205

  Kramarenko, Inga I ^a   Morinelli, Thomas A ^a,b   Bunni, Marlene A ^a,b   Raymond, John R ^c   Garnovskaya, Maria N ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

A498 cells; Extracellular signal regulated protein kinase; G protein coupled receptors; Signal transduction

Indexed keywords

5 (N ISOBUTYL N METHYL)AMILORIDE; BRADYKININ B2 RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; SODIUM PROTON EXCHANGE PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MITOGENESIS; PROTON SODIUM EXCHANGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84930479135     PISSN: None     EISSN: 11791322     Source Type: Journal    
DOI: 10.2147/CMAR.S31847     Document Type: Article

References (54)

1. Cáceres W, Cruz-Chacón A. Renal cell carcinoma: molecularly targeted therapy. P R Health Sci J. 2011;30(2):73-77.
2. Choueiri M, Jonasch E. Have molecularly targeted therapies improved overall survival in renal cell carcinoma? Curr Oncol Reps. 2011;13(3): 153-156.
3. Mukai H, Fitzgibbon WR, Bozeman G, Margolius HS, Ploth DW. Bradykinin B2 receptor antagonist increases chloride and water absorption in rat medullary collecting duct. Am J Physiol. 1996;271(2 Pt 2): R352-R360.
4. Bagaté K, Grima M, Imbs JL, Jong WD, Helwig JJ, Barthelmebs M. Signal transduction pathways involved in kinin B(2) receptor-mediated vasodilation in the rat isolated perfused kidney. Br J Pharmacol. 2001;132(8):1735-1752.
5. El-Dahr SS, Dipp S, Baricos WH. Bradykinin stimulates the ERK--. Elk-1--. Fos/AP-1 pathway in mesangial cells. Am J Physiol. 1998; 275(3 Pt 2):F343-F352.
6. Jaffa AA, Miller BS, Rosenzweig SA, Naidu PS, Velarde V, Mayfield RK. Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol. 1997;273(6 Pt 2):F916-F924.
7. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992;184(1):260-268.
8. Menke JG, Borkowski JA, Bierilo KK, etal. Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 1994;269(34):21583-21586.
9. Mukhin YV, Garnovsky EA, Ullian ME, Garnovskaya MN. Bradykinin B2 receptor activates extracellular signal-regulated protein kinase in mIMCD-3cells via epidermal growth factor receptor transactivation. J Pharmacol Exp Ther. 2003;304(3):968-977.
10. Mukhin YV, Gooz M, Raymond JR, Garnovskaya MN. Collagenase-2 and-3mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells. J Pharmacol Exp Ther. 2006; 318(3):1033-1043.
11. Kramarenko II, Bunni MA, Raymond JR, Garnovskaya MN. Bradykinin B2 receptor interacts with integrin α5/β1 to transactivate epidermal growth factor receptor in kidney cells. Mol Pharmacol. 2010;78(1):126-134.
12. Bhoola K, Ramsaroop R, Plendl J, Cassim B, Dlamini Z, Naicker S. Kallikrein and kinin receptor expression in inflammation and cancer. Biol Chem. 2001;382(1):77-89.
13. Wu J, Akaike T, Hayashida K, etal. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer. 2002;98(1):29-35.
14. Dlamini Z, Bhoola KD. Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma. J Clin Pathol. 2005;58(9):915-922.
15. Chee J, Naran A, Misso NL, Thompson PJ, Bhoola KD. Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer. Biol Chem. 2008;389(9):1225-1233.
16. Greco S, Elia MG, Muscella A, Romano S, Storelli C, Marsigliante S. Bradykinin stimulates cell proliferation through an extracellular signal-regulated protein kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J Endocrinol. 2005;186(2):291-301.
17. Greco S, Storelli C, Marsigliante S. Protein kinase C (PKC)-δ/-ε mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated protein kinases 1 and 2in MCF-7cells stimulated by bradykinin. J Endocrinol. 2006;188(1):79-89.
18. Chan D, Gera L, Stewart J, etal. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism. Proc Natl Acad Sci U S A. 2002;99(7):4608-4613.
19. Schäfer B, Gschwind A, Ullrich A. Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene. 2004;23(4):991-999.
20. Moodley R, Snyman C, Odhav B, Bhoola KD. Visualisation of transforming growth factor-β 1, tissue kallikrein, and kinin and transforming growth factor-β receptors on human clear-cell renal carcinoma cells. Biol Chem. 2005;386(4):375-382.
21. Giard DJ, Aaronson SA, Todaro GJ, etal. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51(5):1417-1423.
22. Wu SY, Pan SL, Chen TH, etal. YC-1induces apoptosis of human renal carcinoma A498cells in vitro and in vivo through activation of the JNK pathway. Br J Pharmacol. 2008;155(4):505-513.
23. Zhang F, Shang D, Zhang Y, Tian Y. Interleukin-22suppresses the growth of A498 renal cell carcinoma cells via regulation of STAT1 pathway. PLoS One. 2011;6(5):e20382.
24. Bertram CM, Baltic S, Misso NL, etal. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration. J Leukoc Biol. 2007;81(6):1445-1454.
25. Mukhin YV, Vlasova T, Jaffa AA, etal. Bradykinin B2 receptors activate Na+/H+ exchange in mIMCD-3cells via Janus kinase 2 and Ca2+/calmodulin. J Biol Chem. 2001;276(20):17339-17346.
26. Kramarenko II, Bunni MA, Morinelli TA, Raymond JR, Garnovskaya MN. Identification of functional bradykinin B2 receptors endogenously expressed in HEK293 cells. Biochem Pharmacol. 2009;77(2):269-276.
27. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, Jaffa AA. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol. 1999;277(2 Pt 1):C253-C261.
28. Wiernas TK, Davis TL, Griffin BW, Sharif NA. Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. Br J Pharmacol. 1998;123(6):1127-1137.
29. Bascands JL, Emond C, Pecher C, Regoli D, Girolami JP. Bradykinin stimulates production of inositol (1,4,5) triphosphate in cultured mesangial cells of the rat via a B2 receptor. Br J Pharmacol. 1991;102(4):962-966.
30. Lefler D, Mukhin YV, Pettus T, Leeb-Lundberd LM, Garnovskaya MN, Raymond JR. Jak2 and Ca2+/calmodulin are key intermediates for bradykinin B2 receptor-mediated activation of Na+/H+ exchange in KNRK and CHO cells. Assay Drug Dev Technol. 2003;1(2):281-289.
31. Tiwari MM, Prather PL, Mayeux PR. Mechanism of bradykinin-induced Ca2+ mobilization in murine proximal tubule epithelial cells. J Pharmacol Exp Ther. 2005;313(2):798-805.
32. Kitamura K, Singer WD, Cano A, Miller RT. G alpha q and G alpha13 regulate NHE-1 and intracellular calcium in epithelial cells. Am J Physiol. 1995;268(1 Pt 1):C101-C110.
33. Lal MA, Proulx PR, Hébert RL. A role for PKC epsilon and MAP kinase in bradykinin-induced arachidonic acid release in rabbit CCD cells. Am J Physiol. 1998;274(4 Pt 2):F728-F735.
34. Adomeit A, Graness A, Gross S, Seedorf K, Wetzker R, Liebmann C. Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol. 1999;19(8):5289-5297.
35. Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal. 2001;13(11): 777-785.
36. Graness A, Hanke S, Boehmer FD, Presek P, Liebmann C. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431cells. Biochem J.2000;347(Pt 2):441-447.
37. Thomas SM, Bhola, NE, Zhang Q, etal. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res. 2006;66(24):11831-11839.
38. Barki-Harrington L, Bookout AL, Wang G, Lamb ME, Leeb-Lundberg LM, Daaka Y. Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem J. 2003;371(Pt 2):581-587.
39. Noël J, Pouysségur J. Hormonal regulation, pharmacology, and membrane sorting of vertebrate Na+/H+ exchanger isoforms. Am J Physiol. 1995;268(2 Pt 1):C283-C296.
40. Bianchini L, L'Allemain G, Pouysségur J. The p42/p44mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE-1 isoform) in response to growth factors. J Biol Chem. 1997;272(1):271-279.
41. Wang H, Silva N, Lucchesi PA, etal. Phosphorylation and regulation of the Na+/H+ exchanger through mitogen-activated protein kinase. Biochemistry. 1997;36(30):9151-9158.
42. Pederson SF, Varming C, Christensen ST, Hoffmann EK. Mechanisms of activation of NHE by cell shrinkage and by calyculin A in Ehrlich ascites tumor cells. J Membr Biol. 2002;189(1):67-81.
43. Garnovskaya MN, Mukhin Y, Raymond JR. Rapid activation of sodium-proton exchange and extracellular signal-regulated protein kinase in fibroblasts by G protein-coupled 5-HT1A receptor involves distinct signalling cascades. Biochem J. 1998;330(Pt 1):489-495.
44. Pedersen SF, Darborg BV, Rentsch ML, Rasmussen M. Regulation of mitogen-activated protein kinase pathways by the plasma membrane Na+/H+ exchanger, NHE1. Arch Biochem Biophys. 2007;462(2): 195-201.
45. Németh ZH, Deitch EA, Szabó C, etal. Na+/H+ blockade inhibits enterocyte inflammatory response and protects against colitis. Am J Physiol Gastrointest Liver Physiol. 2002;283(1):G122-G132.
46. Chen S, Khan ZA, Karmazyn M, Chakrabarti S. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev. 2007;23(5):356-367.
47. Cechin SR, Dunkley PR, Rodnight R. Signal transduction mechanisms involved in the proliferation of C6glioma cells induced by lysophosphatidic acid. Neurochem Res. 2005;30(5):603-611.
48. Mukhin YV, Garnovskaya MN, Ullian ME, Raymond JR. ERK is regulated by sodium-proton exchanger in rat aortic vascular smooth muscle cells. J Biol Chem. 2004;279(3):1845-1852.
49. Karmazyn M, Kilić A, Javadov S. The role of NHE-1in myocardial hypertrophy and remodelling. J Mol Cell Cardiol. 2008;44(4):647-653.
50. Cox GA, Lutz CM, Yang CL, etal. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell. 1997;91(1): 139-148.
51. Cardone RA, Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer. 2005;5(10):786-795.
52. Harguindey S, Orive G, Luis Pedraz J, Paradiso A, Reshkin SJ. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim Biophys Acta. 2005;1756(1):1-24.
53. Liu HF, Teng XC, Zheng JC, Chen G, Wang X-W. Effect of NHE1 antisense gene transfection on the biological behavior of SGC-7901 human gastric carcinoma cells. World J Gastroenterol. 2008;14(14): 2162-2167.
54. Yang X, Wang D, Dong W, Song Z, Dou K. Suppression of Na+/H+ exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion. Med Oncol. 2011;28(1): 385-390.